ProfileGDS5678 / 1418987_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 57% 58% 58% 61% 58% 56% 56% 58% 58% 58% 59% 59% 58% 58% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.4999357
GSM967853U87-EV human glioblastoma xenograft - Control 23.5042758
GSM967854U87-EV human glioblastoma xenograft - Control 33.4948658
GSM967855U87-EV human glioblastoma xenograft - Control 43.6158961
GSM967856U87-EV human glioblastoma xenograft - Control 53.4514858
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.5028656
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.496756
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.4861458
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.4907758
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.478458
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.5333259
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.4932359
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.5050158
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.4937358